Aston Sci.

Developer of therapeutic solutions for the treatment of cancer, CNS diseases, and geriatric diseases

placeSeoul, Seoul, South Korea calendar_todayFounded 2018 groups24 employees language astonsci.com

Registered entities

Innovation

12 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 133 times.

YearFilings
20225
20237
20244
20256

Investor mix

9 investors on record.

Investor typeCountShare
Venture capital333%
Private equity111%
Other / undisclosed556%
Coming soon